Skip to main content

Becton Dickinson and Company (BDX) Stock

Becton Dickinson and Company Stock Details, Movements and Public Alerts

Stock Details

Becton Dickinson and Company (BDX), a prominent company in the life sciences sector within the surgical & medical instruments & apparatus industry, is based in USA and primarily trades on the NYSE.Currently, the stock is trading at $177.08. Over the past 52 weeks, it has ranged between $162.35 and $249.34. This places the current price at 71.0% of its 52-week high and 9.1% above its 52-week low. Recent trading volume was recorded at 6. The International Securities Identification Number (ISIN) for this stock is US0758871091.

Market Cap

$48.97B

52-Week High

$249.34

-28.98% from high

52-Week Low

$162.35

+9.07% from low

Avg Daily Volume

6

Fundamentals

Valuation Metrics

P/E Ratio (TTM)

33.11

Above market average

Forward P/E

11.11

Earnings expected to grow

PEG Ratio

0.85

Potentially undervalued

Price to Book

1.94

EV/EBITDA

14.53

EPS (TTM)

$5.16

Price to Sales

2.35

Beta

0.28

Less volatile than market

How is BDX valued relative to its earnings and growth?
Becton Dickinson and Company trades at a P/E ratio of 33.11, which is above the market average of approximately 20. This premium valuation suggests investors expect above-average growth or the company has competitive advantages justifying the higher multiple. Looking ahead, the forward P/E of 11.11 is lower than the current P/E, indicating analysts expect earnings to grow over the next year. The PEG ratio of 0.85 suggests the stock may be undervalued relative to its growth rate.
What is BDX's risk profile compared to the market?
With a beta of 0.28, Becton Dickinson and Company is less volatile than the overall market. This means when the market moves up or down by 10%, this stock typically moves less than 10% in the same direction. Lower beta stocks are often preferred by conservative investors seeking stability. The price-to-book ratio of 1.94 shows investors value the company above its book value, which often reflects intangible assets or growth prospects.

Performance & Growth

Profit Margin

7.18%

Operating Margin

16.00%

Return on Equity

5.89%

Return on Assets

3.69%

Revenue Growth (YoY)

4.50%

Earnings Growth (YoY)

-42.20%

How profitable and efficient is BDX's business model?
Becton Dickinson and Company achieves a profit margin of 7.18%, meaning it retains $7.18 from every $100 in revenue after all expenses. This relatively low margin suggests the company operates in a competitive environment or high-cost industry where profitability is challenging. The operating margin of 16.00% reveals how efficiently the company runs its core business operations before interest and taxes. With ROE at 5.89% and ROA at 3.69%, the company achieves moderate returns on invested capital.
What are BDX's recent growth trends?
Becton Dickinson and Company's revenue grew by 4.50% year-over-year, showing steady progress in growing the business. This positive trajectory indicates the company maintains competitive positioning in its markets. Earnings decreased by 42.20% year-over-year, reflecting the bottom-line impact of business performance. These growth metrics should be evaluated against SURGICAL & MEDICAL INSTRUMENTS & APPARATUS industry averages for proper context.

Dividend Information

Dividend Per Share

$3.98

Dividend Yield

2.43%

Ex-Dividend Date

6/9/2025

Dividend Date

6/30/2025

What dividend income can investors expect from BDX?
Becton Dickinson and Company offers a dividend yield of 2.43%, paying $3.98 per share annually. This above-average yield of 2-4% provides meaningful income while still allowing the company to reinvest for growth. It compares favorably to the S&P 500 average and offers competitive returns versus bonds in the current rate environment. To receive the next dividend, shares must be purchased before the ex-dividend date of 6/9/2025.
How reliable is BDX's dividend for long-term investors?
The dividend sustainability can be assessed through the payout ratio - Becton Dickinson and Company pays $3.98 per share in dividends against earnings of $5.16 per share, resulting in a payout ratio of 77.13%. This high payout ratio of 60-90% leaves limited earnings for reinvestment. While currently sustainable, there's less buffer for dividend growth or protection during earnings downturns. The next dividend payment is scheduled for 6/30/2025.

Company Size & Market

Shares Outstanding

286.61M

Book Value/Share

$88.07

Asset Type

Common Stock

What is BDX's market capitalization and position?
Becton Dickinson and Company has a market capitalization of $48.97B, classifying it as a large-cap stock ($10B-$200B). Large-caps are typically industry leaders with established business models, offering a balance of stability and growth potential. They often provide dividend income and are core holdings in institutional portfolios. With 286.61M shares outstanding, the company's ownership is relatively concentrated. As a participant in the SURGICAL & MEDICAL INSTRUMENTS & APPARATUS industry, it competes with other firms in this sector.
How does BDX's price compare to its book value?
Becton Dickinson and Company's book value per share is $88.07, while the current stock price is $177.08, resulting in a price-to-book (P/B) ratio of 2.01. This reasonable premium to book value suggests the market values the company's earnings power and intangible assets appropriately. Most profitable companies trade between 1-3x book value. As a common stock, this represents equity ownership with voting rights.

Analyst Ratings

Analyst Target Price

$217.82

23.01% upside potential

Analyst Recommendations

Strong Buy

2

Buy

4

Hold

11

Sell

0

Strong Sell

0

How reliable are analyst predictions for BDX?
17 analysts cover BDX with 35% recommending buy/strong buy ratings. Analyst predictions have mixed reliability - studies show consensus rarely beats market returns consistently. The mixed views reflect uncertainty about the outlook. The consensus target of $217.82 implies 23.0% upside, but targets are often adjusted to follow price moves rather than predict them.
What is the Wall Street consensus on BDX?
Current analyst recommendations:2 Strong Buy, 4 Buy, 11 Hold, 00The neutral stance suggests uncertainty or fair valuation at current levels.Remember that analyst opinions often lag price movements and can be influenced by investment banking relationships.

Fundamentals last updated: Jul 1, 2025, 03:25 AM

Technical Indicators

What does BDX's RSI value tell investors?
RSI data is not available for this stock.
How should traders interpret BDX's MACD and moving average crossovers?
MACD and moving average data are not available for this stock.

No technical indicators available yet.

Active Alerts

No active alerts for this stock.

Be the first to set up an alert for BDX and get notified when the price changes.

Stay Ahead of the Market with Becton Dickinson and Company Alerts

Set up price alerts for Becton Dickinson and Company and get notified instantly when the price hits your target. Never miss an important price movement again.